Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1Genital Neoplasms, Female 1

Interventions

Carboplatin 5Paclitaxel 4pembrolizumab 3Educational Status 3niraparib 2anlotinib 2Therapeutic Touch 2Pemetrexed 2Palliative Care 2Nivolumab 2Methods 2Gemcitabine 2Early Intervention, Educational 2Bevacizumab 2temsirolimus 1rucaparib 1relacorilant 1olaparib 1nintedanib 1nilotinib 1liposomal doxorubicin 1lenvatinib 1fosaprepitant 1atezolizumab 1argatroban 1Watchful Waiting 1Transurethral Resection of Prostate 1Topotecan 1Thrombopoietin 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Genital Neoplasms, Female × argatroban × Clear all
NCT02935530 2019-05-14

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Huazhong University of Science and Technology

Phase 3 Completed
315 enrolled
Classical hematology

Genital Neoplasms, Female, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡